Supplemental Annuity Collective Trust Of Nj Xenon Pharmaceuticals Inc. Transaction History
Supplemental Annuity Collective Trust Of Nj
- $320 Million
- Q2 2024
A detailed history of Supplemental Annuity Collective Trust Of Nj transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Supplemental Annuity Collective Trust Of Nj holds 11,000 shares of XENE stock, worth $449,240. This represents 0.13% of its overall portfolio holdings.
Number of Shares
11,000
Previous 11,000
-0.0%
Holding current value
$449,240
Previous $473,000
9.51%
% of portfolio
0.13%
Previous 0.15%
Shares
1 transactions
Others Institutions Holding XENE
# of Institutions
220Shares Held
69.6MCall Options Held
59.7KPut Options Held
60.7K-
Avoro Capital Advisors LLC New York, NY5.67MShares$231 Million3.02% of portfolio
-
Driehaus Capital Management LLC Chicago, IL4.42MShares$180 Million1.86% of portfolio
-
Wellington Management Group LLP Boston, MA3.83MShares$156 Million0.03% of portfolio
-
Commodore Capital LP New York, NY2.75MShares$112 Million9.63% of portfolio
-
Capital World Investors Los Angeles, CA2.68MShares$110 Million0.02% of portfolio
About Xenon Pharmaceuticals Inc.
- Ticker XENE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,263,500
- Market Cap $2.54B
- Description
- Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...